Neuro-oncology
Neurotrials LLC is involved in clinical research focused on glioblastoma, with particular attention to newly diagnosed disease and treatment options for patients with MGMT promoter unmethylated tumors.
- Glioblastoma
- MGMT promoter unmethylated status
- Newly diagnosed brain cancer
The sponsor’s research activity is centered on therapeutic strategies for aggressive primary brain tumors in adult patients.
Brain tumor treatment
The funded trial landscape includes comparison of systemic therapies used in glioblastoma care, with interest in treatment selection for patients whose tumors lack MGMT promoter methylation.
- Systemic therapy for glioblastoma
- Temozolomide
- Niraparib
This area reflects a focus on therapeutic options that may influence survival outcomes in a difficult-to-treat neuro-oncologic setting.
Adult oncology
Neurotrials LLC supports research in adult patients with central nervous system malignancies, especially those requiring disease-specific treatment approaches for glioblastoma.
- Adult participants
- Central nervous system cancer
- Oncology care
The sponsor’s clinical interest is concentrated on therapeutic decision-making in adult neuro-oncology populations.
Multicenter clinical research
The sponsor’s trial network spans multiple collaborating research sites across several countries, supporting evaluation of glioblastoma therapies in a broad clinical setting.
- Collaborating research sites
- International trial activity
- Recruiting study
This research footprint is aligned with cross-site clinical investigation in a specialized oncology domain.
